Dr. Ashmi Ashley Patel, MD

Dr. Patel practices at Columbia University Irving Medical Center in New York, New York.

Dr. Patel's NPI, 1639287840, was assigned on August 28, 2006. Dr. Patel graduated from University of California, San Francisco School of Medicine in 1998. Dr. Patel holds New York license 215427.

Dr. Patel's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Patel's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Patel is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Patel to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices. Vendor and product names are available with a free account.

Hospitalist is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Patel is licensed in New York.

CMS data shows 297 Medicare services from Dr. Patel across 5 procedure codes in 2024, for 121 Medicare patients. Medicare paid $31,794 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 121 Medicare patients who saw Dr. Patel in 2024. The largest group is 75 to 84, with 44 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 66% are also on Medicaid. Their average risk score is 2.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 75, with 70% women.

In 2024, Dr. Patel wrote 29 Medicare Part D claims for 12 patients. 86% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $44 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Patel for performance year 2024, reported through an alternative payment model (APM). Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Patel, published from 2020 to 2025. 2022 was the busiest year, with 3. The most frequent topics are COVID-19 and SARS-CoV-2. Dr. Patel's most frequent co-authors are Michael Argenziano, MD, Matthew R. Baldwin, MD and Robert Graham Barr, MD.

CMS Open Payments shows 100 general payments to Dr. Patel from 12 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $598.

Dr. Patel graduated from University of California, San Francisco School of Medicine in 1998.